News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
MHRA Grants Approval to Rentschler Biopharma's Advanced Therapy Medicinal Product (ATMP) Facility in Stevenage, UK
Thursday, September 14, 2023Rentschler Biopharma SE a leading global contract development and manufacturing organization CDMO specializing in biopharmaceuticals including advanced therapy medicinal products ATMPs has announced the receipt of the cGMP Manufacturing Compliance Ce...
Adaptive Launches Integration Between Clonoseq® and Epic
Thursday, September 14, 2023Adaptive Biotechnologies Corporation Nasdaq ADPT is a biotechnology company with a focus on leveraging the genetics of the adaptive immune system for clinical applications The company recently announced the integration of its clonoSEQ test into Aura...
Dignify Therapeutics and Aayam Therapeutics Announce Licensing Agreement for a Novel on-demand Bowel Management Medication
Thursday, September 14, 2023Dignify Therapeutics Dignify has recently announced a licensing agreement with Aayam Therapeutics Aayam aimed at developing compound ATX and related proprietary molecules to address ondemand defecation
US FDA Grants Orphan Drug Designation to CyGenica Limited for Innovative Glioblastoma Multiforme Treatment Drug Conjugate
Wednesday, September 13, 2023GBM remains a formidable challenge in the field of oncology demanding innovative and effective treatment solutions CyGenicas Orphan Drug Designation approval for their unique drug conjugate underscores their commitment to addressing the unmet medical...
Pierre Fabre Laboratories Completes Acquisition of Vertical Bio, Advancing Novel Targeted Therapy for Non-Small Cell Lung Cancer Patients with MET Alterations
Wednesday, September 13, 2023Pierre Fabre Laboratories the French pharmaceutical and dermocosmetic company has announced its acquisition of Vertical Bio AG a company specializing in the development of novel cancer therapies
Salipro Biotech and Sumitomo Pharma Announce Collaboration to Advance Drug Discovery Program
Wednesday, September 13, 2023Swedish biotechnology company Salipro Biotech AB has announced a collaborative research effort with Sumitomo Pharma Co Ltd The primary objective of this collaboration is to elucidate the mechanism of action and characterize the pharmacological proper...
Neurocrine Biosciences, Partnering With Sosei Heptares, Launches Phase 1 Clinical Study to Investigate NBI-1117570 Effects in Healthy Adults
Tuesday, September 12, 2023Sosei Group Corporation TSE has been informed by its partner Neurocrine Biosciences Inc Nasdaq NBIX a prominent neurosciencefocused biopharmaceutical firm that it has initiated a Phase clinical study to assess the safety tolerability pharmacokineti...
Hillstream Enters Exclusive Option Agreement for Acquisition of Clinical-stage Therapy Addressing Chronic Pruritis
Tuesday, September 12, 2023Hillstream BioPharma Inc Nasdaq HILS is a biotechnology firm with a focus on developing therapeutic candidates to combat drugresistant cancers
Verona Pharma Receives FDA Acceptance for New Drug Application of Ensifentrine as COPD Maintenance Treatment
Monday, September 11, 2023Verona Pharma trading on Nasdaq as VRNA has announced that the US Food and Drug Administration FDA has accepted the companys New Drug Application NDA for the maintenance treatment of chronic obstructive pulmonary disease COPD with ensifentrine
Tango Therapeutics a Collaborator of Medivir Has Obtained FDA Clearance to Commence the Phase 1/2 Clinical Study for TNG348
Monday, September 11, 2023Medivir AB NASDAQ Stockholm MVIR a pharmaceutical company with a focus on innovative cancer treatments addressing significant unmet medical needs has made an announcement today
